Complex Regional Pain Syndrome Type I of the Upper Limb | Single-port Thoracoscopic Sympathicotomy in Complex Regional Pain Syndrome Type I (CRPS)
Complex Regional Pain Syndrome Type I of the Upper Limb research study
What is the primary objective of this study?
Background of the study: CRPS type-1 is a pain syndrome that usually develops after an initiating noxious event (e.g. fracture) in an extremity. Although treatment options life dimethyl-sulphoxide (DMSO), N-acetylcysteine (NAC) and intensive physical therapy exist, the treatment effect is often unsatisfactory, even leading to amputation of the extremity. Surgical treatment of chronic pain disorders by dividing the sympathetic chain is an established treatment. Its more invasive nature has prevented widespread application. After introduction of minimal invasive techniques in recent years, the UMCG has now devised a truly minimal invasive, yet safe and effective thoracoscopic technique, that requires only a single 1 cm long incision in the anterior axillary line. This technique is developed as treatment for primary focal axillary and palmar hyperhidrosis, and is performed in over 50 patients producing very satisfying results. This fact has led to the hypothesis that this same surgical technique can offer this group of chronic pain patients a safe, effective treatment modality. Objective of the study: The effect of the intervention on pain an regain of function in de affected extremity. This will be quantified in multiple questionnaires at baseline and three follow-up points, and by clinical evaluation of the hand function at baseline and two follow-up points. Study design: Single center prospective feasibility study
Who is eligible to participate?
Inclusion Criteria: Age 18 - 65 years. - ASA 1 en 2. - CRPS-1 defined according to IASP-Bruehl criteria at the wrist or lower arm level. 1. Continuing pain which is disproportionate to any inciting event 2. Must report at least one symptom in each of the four following categories - Sensory: reports of hyperesthesia - Vasomotor: reports of temperature asymmetry, skin color change or asymmetry. - Sudomotor/edema: reports of edema, sweating changes, sweating asymmetry - Motor/trophic: reports of decreased range of motion, motor dysfunction (weakness, tremor, dystonia), trophic changes (hair, nail, skin) 3. Must display at least one sign in two or more of the following categories: - Sensory: evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch) - Vasomotor: evidence of temperature asymmetry, color changes, asymmetry - Sudomotor/edema: evidence of edema, sweating changes, sweating asymmetry - Motor/trophic: evidence of decreased range of motion, motor dysfunction (weakness, tremor, dystonia), trophic changes (hair, nail, skin) Exclusion Criteria: Known COPD > Gold class 1. - History of smoking > 20 pack years, due to higher risk of complications following unilateral lung- deflation and re-insufflation. - Documented substance addiction. - Previous intra-thoracic pleural drainage on affected side. - Previous thoracic surgery on affected side (including sternotomy). - Gross pulmonary or pleural abnormalities on chest X-ray. - Pregnancy, determined by preoperative pregnancy test. - Unsuitable anatomy (e.g. due to severe physical malformations).
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Complex Regional Pain Syndrome Type I of the Upper Limb
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Procedure:unilateral single-port VATS sympathicotomy
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Sympathicotomyunilateral single-port VATS sympathicotomy
Start Date: August 2015
Completed Date: February 2017
Primary Outcome: Change in perceived pain measured in Visual Analogue Scale
Secondary Outcome: Change in function in extremity
Study sponsors, principal investigator, and references
Principal Investigator: Massimo A Mariani, MD, PhD
Lead Sponsor: University of Groningen